Crocker, Gary L.

Crocker, Gary L. Locations SEC CIK 1094201
	Affiliated Entities         Merrimack Pharmaceuticals, Inc.

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Crocker, Gary L. has not been involved in any litigation in the PlainSite database.

Outside Counsel (1)

	Last Name	First Name	Middle Name	Firm	Location
	Essig	Lester	K.	parametricsmedical.com Law Firm Placeholder	SALT LAKE CITY, UT

1 Row Total

Filter By Form All Records 3 4 5 SC 13D From To

	Date	Entity	Form Number	Description
	8/14/2023	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/8/2023	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/13/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/9/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/7/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/26/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/23/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/19/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/16/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	4/25/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	4/1/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	3/29/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	3/24/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	3/17/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	3/15/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	2/23/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	2/18/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	2/16/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	1/31/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	1/27/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	1/25/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	1/20/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	1/18/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	1/13/2022	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/14/2021	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	4/14/2021	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	4/12/2021	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	4/9/2021	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	4/1/2021	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	3/26/2021	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	3/25/2021		4	Statement of changes in beneficial ownership of securities
	3/17/2021	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	3/5/2021	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	2/17/2021		4	Statement of changes in beneficial ownership of securities
	2/12/2021	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	8/3/2020	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	7/24/2020	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	10/21/2019	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/15/2018	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	9/15/2017	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/16/2016	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/18/2015	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	4/10/2015	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	11/14/2014	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	6/24/2014	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/22/2014	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/20/2014	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/15/2014	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/8/2014	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/7/2014	Merrimack Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities

61 Rows Total	Page 1 of 2 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	1/2/1998	Baxter Research Medical, Inc.	Assignee	Application Patent	08924383 6071271	Cardiopulmonary Catheter System Cardiopulmonary Catheter System

1 Row Total

	Date Recorded	Party	Role	Document Type	Document No.	Image
	11/23/2007	1-800-patches, Inc.	Assignor	Trademark	4020253
	11/23/2007	1-800-patches, Inc.	Assignor	Application	78935262
	11/20/2007	Rejuvenation Labs Inc.	Assignee	Application	78935262
	11/20/2007	Rejuvenation Labs Inc.	Assignee	Trademark	4020253

4 Rows Total

Affiliated Entities

• Merrimack Pharmaceuticals, Inc.

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.